Ambulatory blood pressure (BP) monitoring is progressively more used in clinical practice. 1 Several studies have shown that ambulatory BP is superior to clinic BP in predicting prognosis in both untreated and treated hypertensive patients. [1] [2] [3] [4] [5] [6] [7] Concerning treated individuals, it has been shown that patients with controlled ambulatory BP are at lower risk than those with uncontrolled ambulatory BP, independently of clinic BP. [5] [6] [7] Ambulatory BP monitoring has revealed that circadian BP profile is not uniform. Indeed, according to nighttime BP fall, hypertensive subjects are divided in dippers (nighttime BP fall ≥ 10%) and nondippers (nighttime BP fall < 10%). In addition, ambulatory BP monitoring has given the possibility to evaluate the morning surge (MS) of BP, that is the difference between BP after and before awakening, which has been involved in the occurrence of cardiovascular events given their reported peak incidence in the morning. 8, 9 Various studies have evaluated cardiovascular outcome according to nighttime BP pattern or MS of BP in both untreated and treated hypertensive patients suggesting increased risk in those with nondipping pattern or high MS. In such a context, however, there are few data about the prognostic relevance of circadian BP changes in treated hypertensive patients with controlled ambulatory BP. Indeed, to the best of our knowledge, there are 2 studies in the literature evaluating the prognostic impact of nondipping in subjects with normal ambulatory BP 31,32 and there is no study assessing the prognostic influence of high MS in the same setting.
METHODS

Subjects
Since 1992, we built two prospective databases of our initially untreated or initially treated hypertensive patients with the purpose to evaluate the prognostic value of ambulatory BP parameters and other risk markers. The present study is one of those carried out with the database of initially treated subjects. We studied 391 patients with normal achieved ambulatory BP during treatment who were selected from 1191 sequential treated hypertensive patients aged ≥60 years (range, 60-90 years) prospectively recruited from December 1992 to 2012 and who were referred to our hospital outpatient clinic for evaluation of BP control. Sixty-two patients were lost during follow-up. Subjects with secondary hypertension were excluded. All the patients underwent clinical evaluation, electrocardiogram, routine laboratory tests, echocardiographic examination, and noninvasive ambulatory BP monitoring. Study population came from the same geographical area (Chieti and Pescara, Abruzzo, Italy). The study was in accordance with the Second Declaration of Helsinki and was approved by the institutional review committee. Subjects gave informed consent.
Office BP measurements
Clinic systolic and diastolic BP recordings were performed by a physician by using a mercury sphygmomanometer and appropriate-sized cuffs. Phase V was used to determine diastolic BP. Measurements were performed in triplicate, 2 minutes apart, and the mean value was used as the BP for the visit.
Ambulatory BP monitoring
Ambulatory BP monitoring was performed with a portable noninvasive recorder (SpaceLabs 90207, Redmond, WA) on a day of typical activity, within 1 week from clinic BP measurement. Each time a reading was taken, subjects were instructed to remain motionless and to record their activity on a diary sheet. Ambulatory BP readings were obtained at 15-minute intervals from 6 am to midnight, and at 30-minute intervals from midnight to 6 am. The following ambulatory BP parameters were evaluated: daytime (awake period), nighttime (asleep period), and 24-hour systolic and diastolic BP, weighted SD of 24-hour BP as an index of BP variability according to the formula [(daytime SD × awake time in hours) + (nighttime SD × asleep time in hours)]/24, the extent of BP reduction from day to night (those with BP fall <10% were defined as nondippers and those with BP fall ≥10% as dippers), and preawakening MS of BP defined as the difference between the mean BP during the 2 hours after waking and the mean BP during the 2 hours before waking evaluated separately in dippers and nondippers. As previously reported, 26, [28] [29] [30] in this population we divided nondippers and dippers according to group-specific tertiles of MS of systolic BP; dippers with MS in the upper tertile (>23 mm Hg) were defined as having high MS.
Controlled ambulatory BP was defined as both daytime BP <135/85 mm Hg and nighttime BP <120/70 mm Hg.
Recordings were automatically edited (that is, excluded) if systolic BP was >260 or <70 mm Hg or if diastolic BP was >150 or <40 mm Hg and pulse pressure was >150 or <20 mm Hg. Subjects had recordings of good technical quality (at least 70% of valid readings).
In this population, from exploratory analysis, systolic BP was a better predictor of cardiovascular outcome than diastolic BP. Moreover, it has been reported that systolic BP is superior to diastolic BP in predicting prognosis in older subjects. 33 Thus, in the present study, we used systolic BP to evaluate nondipping and MS of BP.
Echocardiography
Left atrial (LA) and left ventricular (LV) measurements and calculation of LV mass were made according to standardized methods. 34 LA diameter (cm) was indexed by body surface area (m 2 ) and LA enlargement was defined as LA diameter/body surface area ≥2.4 cm/m 2 . 34 LV mass was indexed by height 2.7 and LV hypertrophy was defined as LV mass/height 2.7 >50 g/m 2.7 in men and >47 g/m 2.7 in women. 35 LV ejection fraction was calculated using the Teichholz formula or the Simpson rule 34 and defined as low when it was <50%.
Follow-up
Subjects were followed-up in our hospital outpatient clinic or by their family doctors. The occurrence of cardiovascular events was recorded during follow-up visits or by telephone interview of the patient followed by a clinical visit. Data were collected by the authors of this study. Those reviewing the endpoints were blinded to other patients' data. In the present report, we evaluated a combined end-point including fatal and nonfatal stroke, coronary events (sudden death, fatal and nonfatal myocardial infarction, and coronary revascularization), heart failure with reduced or preserved ejection fraction requiring hospitalization, and peripheral revascularization. Outcomes were defined as previously reported. 26, [28] [29] [30] 
Statistical analysis
Standard descriptive statistics were used. Groups were compared by using 1-way analysis of variance followed by a multiple comparison test and chi-square or Fisher's exact test with Bonferroni's correction, where appropriate. Event rates are expressed as the number of events per 100 patientyears based on the ratio of the observed number of events to the total number of patient-years of exposure up to the terminating event or censor. Survival curves were estimated using the Kaplan-Meier product-limit method and compared by the Mantel (log-rank) test. Cox regression analysis was used to evaluate univariate and multivariate association of factors with outcome. First, we evaluated univariate association between cardiovascular events and age, gender, body mass index, smoking habit, previous events, diabetes, estimated glomerular filtration rate, low-density lipoprotein cholesterol, LV hypertrophy, asymptomatic LV systolic dysfunction at baseline, LA enlargement, clinic and 24-hour, daytime and nighttime BP, ambulatory BP groups (dippers with normal MS as reference group and dippers with high MS and nondippers as comparing groups), weighted systolic BP SD, antihypertensive, antiplatelet and statin therapy at baseline, and atrial fibrillation occurred during follow-up. Then, multiple regression analysis was performed reporting in the final model variables that were significantly (P < 0.05) associated with outcome in univariate analysis. The forced entry model was used. Statistical significance was defined as P <0.05. Analyses were made with the SPSS 21 software package (SPSS, Chicago, IL). Graphs were made with Microsoft Excel 10 (Microsoft Corporation, Redmond, WA) and GraphPad Prism 7 (GraphPad software, San Diego, CA).
RESULTS
Characteristics and BP values of the study groups are summarized in Table 1 . Age tended to be lower in dippers with normal MS and prevalence of men tended to be higher in dippers with high MS but both of them did not attain statistical significance. Clinic and daytime BP were higher in dippers with high MS than in the other groups. Nighttime systolic and diastolic BP were higher in nondippers by definition. Twenty-four-hour systolic BP was higher in dippers with high MS. Dipping and MS of systolic BP were different by definition. Weighted systolic BP SD was higher in dippers with high MS. Other variables were not significantly different among the groups.
Baseline antihypertensive therapy is reported in Table 2 . Use of diuretics, beta-blockers, calcium antagonists, angiotensin converting enzyme inhibitors, angiotensin receptor blockers and alpha-blockers, as well as single, double and triple therapy, were not significantly different among the groups. At baseline, use of aspirin and statin were not significantly different among dippers with normal MS, dippers with high MS, and nondippers (19 vs. 17 vs. 24%, respectively, P = 0.38, and 12 vs. 17 vs. 11%, respectively, P = 0.52).
During the follow-up (9.3 ± 4.6 years; range, 0.5-20 years), 76 cardiovascular events occurred. Specifically, there were 24 strokes, 33 coronary events, 18 heart failures (10 with preserved and 8 with reduced ejection fraction) and 1 peripheral revascularization. The event-rate of the global population was 2.09 per 100 patient-years. There were 22, 16, and 38 events in dippers with normal MS, dippers with high MS, and nondippers, respectively. Event-rate and event-free survival curves of study groups are reported in Figures 1 and 2 , respectively.
Univariate analysis showed that age, gender, LV hypertrophy, asymptomatic LV systolic dysfunction at baseline, LA enlargement, dipping with high MS, and nondipping were significantly associated with increased cardiovascular risk (Table 3 ). There was no significant association between cardiovascular risk and other variables.
We performed a multivariate analysis including age, gender, LV hypertrophy, asymptomatic LV systolic dysfunction at baseline, LA enlargement, and circadian BP subgroups.
Results of multivariate analysis are reported in Figure 3 . After adjustment for the above-mentioned covariates, the risk of cardiovascular events was significantly higher in dippers with high MS and nondippers when compared to dippers with normal MS. If clinic and 24-hour systolic BP were forced into the model, results remained substantially the same. Indeed, compared to dippers with normal MS, dippers with high MS (hazard ratio 2.52, 95% confidence interval 1.29-4.93, P = 0.007), and nondippers (hazard ratio 2.09, 95% confidence interval 1.19-3.68, P = 0.01) remained at higher cardiovascular risk.
DISCUSSION
This study shows that circadian BP changes predict cardiovascular risk independently of other risk markers in elderly treated hypertensive patients with normal achieved ambulatory BP.
Several studies have previously evaluated the prognostic value of circadian BP changes in hypertensive patients, but there are only few data 31, 32 in hypertensive patients with normal ambulatory BP about this issue. Ohkubo et al. 31 studied 1542 residents in Ohasama who were aged 40 years or more and were representative of the Japanese general population. Mean follow-up duration was 9.2 years. Among these subjects, 1208 had normal 24-h BP (<135/80) and included normotensive subjects and treated hypertensive patients (27%). In this subpopulation, nondippers were found to be at higher risk of cardiovascular mortality than dippers (hazard ratio 2.35, 95% confidence interval 1.19-5.97). Hermida et al. 32 studied 3344 individuals during a median follow-up of 5.6 years. Among these subjects, according to the final evaluation, 1992 had normal ambulatory BP (that is, awake BP <135/85 mm Hg and asleep BP <120/70 mm Hg) and included normotensive subjects and treated hypertensive patients (59%). In this sample, nondippers were at higher cardiovascular risk than dippers (hazard ratio 1.61, 95% confidence interval 1.09-2.37). When individuals with normal ambulatory BP were subdivided in untreated and treated ones, nondippers were at higher cardiovascular risk than dippers among both untreated and treated subjects (hazard ratio 2.44, 95% confidence interval 1.07-5.61, and hazard ratio 1.48, 95% confidence interval 1.01-2.26, respectively).
The above-mentioned studies showed that cardiovascular risk is influenced by nighttime BP decline even in the presence of normal ambulatory BP. 31, 32 Our study population is different from that reported by Ohkubo et al. 31 including normotensive subjects and treated hypertensive patients. Although our patients resemble treated population assessed by Hermida et al., 32 there are differences including patients' classification (according to baseline ambulatory BP pattern in our study and according to final ambulatory BP profile in the study by Hermida et al. 32 ) and mean age of populations (about 69 years in our study and approximately 51 years in the study by Hermida et al. 32 ). Notwithstanding these differences, our results are in line with previous findings and extend them.
Concerning the prognostic value of high MS, to the best of our knowledge, this is the first study in the literature reporting increased cardiovascular risk in dippers with high MS than in dippers with normal MS in the context of normal achieved ambulatory BP.
Since the first descriptions of nondipping 10 and high MS 23 there was an attempt to explain the mechanisms by which they are associated with increased cardiovascular risk. Beyond the detrimental effect of persistent 24-hour BP load in nondippers and sudden increase of BP load in the morning in patients with high MS, various other hypotheses have been formulated and discussed in previous reports. [36] [37] [38] Blunted nocturnal BP fall has been shown to be associated with autonomic nervous system dysfunction, elevated myocardial repolarization lability, sleep-related breathing disorders, hyperaldosteronism, chronic low-grade inflammation, increased platelet activation, alterations in hemostasis, endothelial dysfunction, and increased myocardial fibrosis. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [29] [30] [31] [32] 36 High MS has been described to be associated with increased arterial stiffness, increased oxidative stress, chronic low-grade inflammation, increased platelet activation, alterations in hemostasis, and coronary microvascular dysfunction. [23] [24] [25] [26] [27] [28] [29] [30] 37, 38 It could be speculated that some of the above-mentioned alterations continue to exert their damaging effect despite normal achieved ambulatory BP. Smokers, n (%) 22 (12) 8 (15) 15 (9) 0.52
Previous events, n (%) 12 (7) 6 (11) 14 (9) 0.54 Diabetes, n (%) 16 (9) 1 (2) 17 (11) This study has some limitations. First, we studied only Caucasian subjects and our results cannot be applied to other ethnic groups. Second, our data were obtained in elderly treated hypertensive patients and cannot be extrapolated to younger and untreated subjects. Third, it remains unclear whether circadian BP changes entirely reflect an intrinsic characteristic of patients or uncontrolled BP because of treatment features (dosage or timing of drug therapy); these aspects however do not lessen our findings. Fourth, the lack of association of cardiovascular risk with treatment strategy does not mean lack of efficacy of therapy because all subjects were treated with antihypertensive therapy, most of whom received multiple therapy, and patients were not randomized to antihypertensive or antiplatelet or statin therapy. Fifth, at present, the reproducibility of MS is not yet completely clear [39] [40] [41] [42] ; however, independently of this aspect it has been frequently shown that high MS is associated with increased cardiovascular risk. [23] [24] [25] [26] [27] [28] [29] [30] 37, 38 In conclusion, in elderly treated hypertensive patients with normal achieved ambulatory BP, dippers with high MS, and nondippers are at increased cardiovascular risk than dippers with normal MS. Our findings suggest that once achieved normal ambulatory BP, further adjustment of therapy should be made to improve nighttime BP reduction in nondippers and reduce MS of BP in patients with high MS in order to better prevent cardiovascular events in elderly treated hypertensive patients.
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